These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38066723)
21. Multiple B cell malignancies in patients with chronic lymphocytic leukemia: epidemiology, pathology, and clinical implications. Parikh SA; Meacham PJ; Zent CS; Evans AG Leuk Lymphoma; 2020 May; 61(5):1037-1051. PubMed ID: 31928278 [TBL] [Abstract][Full Text] [Related]
22. Update on bi-specific monoclonal antibodies for blood cancers. Shouse G Curr Opin Oncol; 2023 Sep; 35(5):441-445. PubMed ID: 37551951 [TBL] [Abstract][Full Text] [Related]
23. Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies. Danilov AV; Persky DO Br J Haematol; 2021 Apr; 193(1):15-25. PubMed ID: 33216986 [TBL] [Abstract][Full Text] [Related]
24. PD-1/PD-L1 inhibitors in haematological malignancies: update 2017. Jelinek T; Mihalyova J; Kascak M; Duras J; Hajek R Immunology; 2017 Nov; 152(3):357-371. PubMed ID: 28685821 [TBL] [Abstract][Full Text] [Related]
25. Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas. Martens AWJ; Rietveld JM; de Boer R; Peters FS; Ngo A; van Mil LWHG; de Heer K; Spaargaren M; Verkleij CPM; van de Donk NWCJ; Adams HC; Eldering E; van Noesel CJM; Verona R; Kater AP Cancer Res Commun; 2022 May; 2(5):330-341. PubMed ID: 36875718 [TBL] [Abstract][Full Text] [Related]
26. Bendamustine: a review of its use in the management of chronic lymphocytic leukaemia, rituximab-refractory indolent non-Hodgkin's lymphoma and multiple myeloma. Hoy SM Drugs; 2012 Oct; 72(14):1929-50. PubMed ID: 22950536 [TBL] [Abstract][Full Text] [Related]
27. Epidemiology and Predictors of 30-Day Readmission in CAR-T Cell Therapy Recipients. Sharma A; Singh V; Deol A Transplant Cell Ther; 2023 Feb; 29(2):108.e1-108.e7. PubMed ID: 36371048 [TBL] [Abstract][Full Text] [Related]
28. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study. Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619 [TBL] [Abstract][Full Text] [Related]
29. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R; Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467 [TBL] [Abstract][Full Text] [Related]
31. Novel and Expanded Oncology Drug Approvals of 2016-PART 2: New Options in the Management of Hematologic Malignancies. Knepper TC; Saller J; Walko CM Oncology (Williston Park); 2017 Feb; 31(2):138-46. PubMed ID: 28205194 [TBL] [Abstract][Full Text] [Related]
32. Risk of mature B-cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network. Kane E; Painter D; Smith A; Lamb M; Oliver SE; Patmore R; Roman E Int J Cancer; 2020 Aug; 147(3):702-708. PubMed ID: 31675431 [TBL] [Abstract][Full Text] [Related]
33. Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development. Davies A; Berge C; Boehnke A; Dadabhoy A; Lugtenburg P; Rule S; Rummel M; McIntyre C; Smith R; Badoux X Adv Ther; 2017 Oct; 34(10):2210-2231. PubMed ID: 28983819 [TBL] [Abstract][Full Text] [Related]
34. Differences and similarities between LC-MS derived serum fingerprints of patients with B-cell malignancies. Piszcz J; Lemancewicz D; Dudzik D; Ciborowski M Electrophoresis; 2013 Oct; 34(19):2857-64. PubMed ID: 24228264 [TBL] [Abstract][Full Text] [Related]